News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Intercept Pharmaceuticals, Kythera Biopharmaceuticals Take Off in IPOs



10/12/2012 10:28:52 AM

A pair of biopharmaceutical IPOs rose sharply in early Thursday trading, gaining ground after each company upped the number of shares they brough to market. Kythera Biopharmaceuticals Inc.'s (KYTH) rose $3.79, or 24%, to close at $19.79. The stock opened at $18.49, up 16% from the the $16 offer price, and continued to rise during Thursday's session.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES